Physician profile
Christopher S Dibello
NPI 1487875977
$33,334.76
in general payments reported to CMS, 2019-2025
51 companies · $2,610 in 2025
The $2,610 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,637 · 2020: $3,244 · 2021: $9,849 · 2022: $2,796 · 2023: $6,232 · 2024: $1,967 · 2025: $2,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,064 · Education: $3,195 · Travel and Lodging: $870 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,063.70 |
| Education | $3,195.29 |
| Travel and Lodging | $869.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $680.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19,145.06 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Intuitive Surgical, INC. | $4,255.05 | 2023-2025 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,319.19 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,880.74 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $741.82 | 2019-2025 | Dupixent |
| Philips North America LLC | $577.85 | 2019-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $535.14 | 2019-2025 | |
| Amgen INC. | $459.52 | 2021-2025 | Tezspire |
| Ethicon INC. | $382.47 | 2020-2025 | Monarch Platform |
| Insmed, INC. | $271.12 | 2021-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $246.75 | 2019-2024 | Yupelri |
| Boston Scientific Corporation | $216.31 | 2021-2024 | Acquire, Spyglass Discover |
| Abbvie INC. | $181.47 | 2023-2025 | Avycaz, Teflaro |
| Pulmonx Corporation | $174.07 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Veran Medical Technologies, INC. | $146.90 | 2020 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $136.53 | 2025 | Aliya System |
| Electromed, INC. | $125.83 | 2023-2025 | Smartvest |
| Jazz Pharmaceuticals INC. | $124.87 | 2023 | |
| Inogen, INC. | $119.91 | 2021-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Takeda Pharmaceuticals U.S.A., INC. | $97.27 | 2022-2024 | Glassia |
| Novartis Pharmaceuticals Corporation | $85.71 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $84.45 | 2019-2025 | Keytruda, Zerbaxa |
| Teva Pharmaceuticals USA, INC. | $79.90 | 2021-2024 | Austedo Xr, Airduo Digihaler |
| Actelion Pharmaceuticals US, INC. | $74.38 | 2021-2025 | Uptravi, Opsynvi |
| Mallinckrodt Hospital Products INC. | $63.04 | 2024-2025 | Acthar |
| Sk Life Science, INC. | $62.82 | 2023-2025 | |
| Grifols USA, LLC | $55.31 | 2020-2024 | Prolastin-C Liquid |
| Sanofi-Aventis U.S. LLC | $54.99 | 2023 | |
| Ucb, INC. | $54.05 | 2023-2024 | Rystiggo |
| Baxter Healthcare | $45.11 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Sunovion Pharmaceuticals INC. | $41.94 | 2019-2020 | |
| Lilly USA, LLC | $39.88 | 2025 | Zepbound |
| Astellas Pharma US INC | $38.96 | 2023 | Cresemba |
| Fisher & Paykel Healthcare INC | $38.02 | 2024-2025 | Fisher & Paykel Healthcare |
| Paratek Pharmaceuticals, INC. | $36.42 | 2021 | |
| Covidien LP | $34.83 | 2020 | |
| Avadel Cns Pharmaceuticals, LLC | $30.90 | 2025 | Lumryz |
| Allergan, INC. | $28.59 | 2019-2020 | |
| Inari Medical, INC. | $27.50 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Optinose US, INC. | $24.40 | 2024 | |
| Janssen Pharmaceuticals, INC | $24.30 | 2022 | |
| Microtransponder, INC. | $22.66 | 2024 | |
| Viatris Specialty LLC | $20.46 | 2025 | Yupelri |
| Resmed Corp | $20.42 | 2024 | |
| Tactile Systems Technology INC | $18.18 | 2023 | Flexitouch Plus, Entre Plus |
| Lundbeck LLC | $17.09 | 2022 | |
| Eisai INC. | $16.63 | 2025 | |
| Hikma Pharmaceuticals USA | $15.68 | 2024 | Ryaltris |
| Pfizer INC. | $14.04 | 2024 | |
| Advanced Respiratory, INC | $13.75 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dibello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.